[Imogam rage prescription assessment in the rabies prophylaxis center of Poitiers].
OBJECTIVE
Imogam rage (IgR) prescriptions were assessed in the rabies prophylaxis centre of Poitiers (France).


METHODS
All medical records closed between January 1 and June 1, 2005 were retrospectively analyzed. An infectious disease specialist examined the pertinence of IgR prescription according to WHO references adapted to the epidemiological situation by the Pasteur Institute French rabies center. The indicator used was the proportion of patients treated by IgR among all patients treated by vaccination or vaccination with IgR.


RESULTS
During the study period, 69 medical records have bewereen analyzed: 48 (70%) patients were treated including 22 (46%) with IgR. Imogam rage indication was not appropriate for 21 (95%) patients (one contact with a rodent, 8 low gravity contact, 12 contacts with a French animal) that is to say 86 IgR vials. The direct cost was 8,032 euros.


CONCLUSIONS
This assessment permitted to underline an overprescription of IgR, to adapt guidelines to the local situation, and to improve care quality by adaptating medical record files, improving the prescription decisional tree and the local guidelines, and improving the training of interns.
Albouy-Llaty
M
M
Service des Maladies Infectieuses, Centre Antirabique, CHU de Poitiers, 2, rue de la Milétrie, BP 577, 86021 Poitiers cedex, France.
Le Moal
G
G
Bouche
G
G
Dupuis
A
A
Becq-Giraudon
B
B
Migeot
V
V
D000465:Algorithms; D000818:Animals; D000829:Animals, Domestic; D000835:Animals, Wild; D001733:Bites and Stings / Q000628:therapy; D019090:Case Management; D002685:Chiroptera; D016527:Drug Costs; D011307:Drug Prescriptions / Q000706:statistics & numerical data; D004363:Drug Utilization; D004781:Environmental Exposure; D005602:France; D006268:Health Facilities / Q000706:statistics & numerical data; D006801:Humans; D016233:Immunotherapy, Active / Q000191:economics / Q000706:statistics & numerical data; D011818:Rabies / Q000517:prevention & control* / Q000635:transmission; D011819:Rabies Vaccines / Q000191:economics / Q000627:therapeutic use*; D012377:Rodentia; D019564:Unnecessary Procedures
C520376:Imogam rage; D011819:Rabies Vaccines